Roman R. Krestinin
Moscow, MOW 142290, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Astaxanthin Reduces H2O2- and Doxorubicin-Induced Cardiotoxicity in H9c2 Cardiomyocyte Cells.
Journal: Biochemistry. Biokhimiia
Published: November 10, 2024
Astaxanthin Protects Against H2O2- and Doxorubicin-Induced Cardiotoxicity in H9c2 Rat Myocardial Cells.
Journal: Life (Basel, Switzerland)
Published: September 20, 2024
Potential Targets for the Protective Effect of Astaxanthin on Ethanol-induced Damage in Rat Liver Mitochondria.
Journal: Current medicinal chemistry
Published: April 02, 2024
Melatonin Enhances the Effect of ABT-737 in Acute Monocytic Leukemia THP-1 Cells
Journal: Molekuliarnaia biologiia
Published: May 16, 2023
Melatonin Can Enhance the Effect of Drugs Used in the Treatment of Leukemia.
Journal: Biochemistry. Biokhimiia
Published: April 17, 2023
The Effect of Astaxanthin on Mitochondrial Dynamics in Rat Heart Mitochondria under ISO-Induced Injury.
Journal: Antioxidants (Basel, Switzerland)
Published: April 04, 2023
The Improvement of Functional State of Brain Mitochondria with Astaxanthin in Rats after Heart Failure.
Journal: International journal of molecular sciences
Published: November 14, 2022
Astaxanthin Is Able to Prevent Alcohol-Induced Dysfunction of Liver Mitochondria.
Journal: Antioxidants (Basel, Switzerland)
Published: September 05, 2022
The Identification of Prohibitin in the Rat Heart Mitochondria in Heart Failure.
Journal: Biomedicines
Published: November 15, 2021
Mitochondrion as a Target of Astaxanthin Therapy in Heart Failure.
Journal: International journal of molecular sciences
Published: July 02, 2021
Melatonin Can Modulate the Effect of Navitoclax (ABT-737) in HL-60 Cells.
Journal: Antioxidants (Basel, Switzerland)
Published: October 29, 2020
Last Updated: 09/26/2026